TP53 and prostate cancer: In the context of prostate cancer, the modulation of lactate levels alongside the inhibition of PD-1-mediated immunosuppression in macrophages plays a crucial role in regulating the proliferation of prostate cancer cells that are deficient in PTEN and p53.